PMH25 CLINICAL OUTCOMES AND ECONOMIC COSTS OF SECOND-GENERATION ANTIPSYCHOTICS IN PATIENTS WITH CHRONIC SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDERS
May 1, 2011, 00:00
10.1016/j.jval.2011.02.1049
https://www.valueinhealthjournal.com/article/S1098-3015(11)01188-0/fulltext
Title :
PMH25 CLINICAL OUTCOMES AND ECONOMIC COSTS OF SECOND-GENERATION ANTIPSYCHOTICS IN PATIENTS WITH CHRONIC SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDERS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01188-0&doi=10.1016/j.jval.2011.02.1049
First page :
A190
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
532